AEA GISE

patient antithrombotic therapy elderly acute coronary syndrome gise tolove

With an aging population in the Western world, a growing proportion of patients treated in praticacardiologica is represented by the elders.

Although about a third of patients admitted with acute coronary syndrome (ACS) is older than 75 years and the mortality rate in this age group has doubled compared to younger patients, this population is underrepresented in randomized controlled trials and, therefore, the guidelines often do not provide clear guidance for the management of elderly patients.

Therefore, there is need for clinical guidance regarding this subpopulation dipazienti with SCA growing rapidly, considering the fact claws decisions on the optimal antithrombotic therapy strategies in the elderly are often difficult and complex, also in relation to the presence of dysfunction d ' age-related organ, frequent comorbidity and multiple concomitant medications, and ultimately increase the risk of both ischemic stroke is hemorrhagic in elderly patients.

An expert panel of cardiologists rallied under the aegis of Italian Society of Interventional Cardiology (SICI-GISE) to discuss the issue and develop a consensus document, in order to provide practical recommendations on the clinical cardiologist and interventionist on the optimal management of antithrombotic therapy in ACS patients over the age of 75 years.

In this position paper are presented and discussed various clinical scenarios of patients with acute myocardial infarction with or without elevation trattoST and unstable angina, including special cases (eg. Patients over equal 85anni, patients with kidney disease or with known cerebrovascular accident, patients requiring triple therapy or long-term antithrombotic therapy), providing the Panelper recommendations every single scenario.